EMPRANDO Trademark

Trademark Overview


On Monday, October 25, 2021, a trademark application was filed for EMPRANDO with the United States Patent and Trademark Office. The USPTO has given the EMPRANDO trademark a serial number of 79329099. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, August 14, 2024. This trademark is owned by NOVARTIS AG. The EMPRANDO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention a...

Medical injection devices for the administration of pharmaceutical preparations for the delivery of anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antifungal preparations, antivirals, cardiovascular pharmaceuticals, dermatological pharmaceutical preparations, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for use in hematology and in tissue and organ transplantation, pharmaceutical preparations for the prevention and treatment of eye diseases and conditions, pharmaceutical preparations for the prevention and treatment of heart rhythm disorders, pharmaceutical preparations for the prevention and treatme...
emprando

General Information


Serial Number79329099
Word MarkEMPRANDO
Filing DateMonday, October 25, 2021
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, August 14, 2024
Registration Number6926967
Registration DateTuesday, December 20, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; vaccines
Goods and ServicesMedical injection devices for the administration of pharmaceutical preparations for the delivery of anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antifungal preparations, antivirals, cardiovascular pharmaceuticals, dermatological pharmaceutical preparations, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for use in hematology and in tissue and organ transplantation, pharmaceutical preparations for the prevention and treatment of eye diseases and conditions, pharmaceutical preparations for the prevention and treatment of heart rhythm disorders, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, pharmaceutical preparations for the prevention and treatment of kidney diseases, pharmaceutical preparations for the prevention and treatment of diabetes, pharmaceutical preparations for the prevention and treatment of hypertension, pharmaceutical preparations for the prevention and treatment of skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical preparations for use in ophthalmology, pharmaceutical preparations for the prevention and treatment of cancer and tumors, pharmaceutical preparations for the prevention and treatment of allergies, pharmaceutical preparations for the prevention and treatment of bone diseases, pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma and vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, August 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, August 14, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, December 23, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, January 5, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, January 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, January 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 26, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, January 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 7, 2022ASSIGNED TO EXAMINER
Tuesday, February 8, 2022NON-FINAL ACTION WRITTEN
Wednesday, February 9, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 8, 2022REFUSAL PROCESSED BY MPU
Tuesday, March 8, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, March 27, 2022REFUSAL PROCESSED BY IB
Wednesday, July 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2022ASSIGNED TO EXAMINER
Wednesday, August 31, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 14, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 14, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, October 3, 2022NOTIFICATION PROCESSED BY IB
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, April 5, 2023FINAL DISPOSITION PROCESSED
Monday, March 20, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, August 31, 2024DEATH OF INTERNATIONAL REGISTRATION
Saturday, August 31, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, April 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 5, 2023FINAL DISPOSITION NOTICE SENT TO IB